A look at the most popular stories at MedCity News for 2016 from drug patent expirations to analysis on telemedicine company HealthSpot's demise and a timeline charting the rise and fall of Theranos.
Monday's auction for the assets and intellectual property of bankrupt telehealth company HealthSpot didn't last long, nor was it "frothy," as the bankruptcy trustee had predicted.
With two competing bids received before Wednesday's deadline. the U.S. Bankruptcy Court in Columbus, Ohio, will hold an auction Monday.
The bankruptcy trustee is now accepting offers for HealthSpot's assets, including 191 telemedicine kiosks, most of which have never been used.
How quickly things can change from promise to disappointment in healthcare innovation.
HealthSpot listed assets of $5.2 million and liabilities of $23.3 million, and only generated $1.1 million in revenues over three years.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Also, an infograph of which drugs are going off-patent in 2016, a company that's taking a similar approach to Theranos, and the 200th birthday of the stethoscope.
This week we are taking advantage of having our own Stephanie Baum live at CES in Las Vegas for MedHeads' Friday broadcast. We will also have input from special guest, John Lynn, healthcare entrepreneur and blogger.
Xerox built some of HealthSpot's technology and, in November 2014, invested an undisclosed sum in Dublin, Ohio-based HealthSpot.
So far, attempts to reach HealthSpot CEO Steve Cashman have been unsuccessful, so we haven't heard the company's explanation for why it failed. It's left to others to speculate.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Two of the Dublin, Ohio-based vendor's most prominent partners confirmed to MedCity News on Tuesday that they were no longer working with HealthSpot.
This post is sponsored by Disrupted. The Business of Healthcare. Technology and access are two objectives, which have come together in new and disruptive ways to change the primary care landscape. One such disruption is telemedicine, a significant trend in digital health this year, according to Skip Fleshman, partner at Asset Management Ventures, in a […]
The Cleveland Clinic and Cox Communications, the nation’s third-largest cable and broadband provider, have jointly formed a venture that aims to bring in-home telehealth services to possibly millions of consumers. The collaboration, dubbed Vivre Health, comes amid significant and growing interest in telehealth services, not just from healthcare providers but also for Cox and other […]
Fresh from deals with strategic partners Xerox and Rite Aid, telemedicine kiosk provider HealthSpot is expected to detail a new round of funding of more than $11 million from four investors soon, according to a Form D filing with the Securities and Exchange Commission. Although MedCity News has learned the financing round includes a strategic […]
HealthSpot, which recently announced a big collaboration with Xerox and a pilot with Rite Aid pharmacies in Ohio to use its telehealth kiosks, is looking to raise $6 million, according to a filing with the the SEC. The Ohio-based company develops fully enclosed, 40 square-foot kiosks that can seemingly be implemented anywhere, from the Cleveland […]
